![Stuart Duty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stuart Duty
Director/Board Member at
EYEPOINT, INC.
Net worth: - $ as of 2026-07-30
Profile
Stuart M.
Duty is an Independent Director at EyePoint, Inc. since 2023, an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. since 2024, and an Independent Director at Foghorn Therapeutics, Inc. since 2025.
Former roles include Managing Director-Healthcare Investment Banking at Montgomery Securities, Inc. from 1993 to 1999, Senior Managing Director at Guggenheim Partners LLC from 2012 to 2023, Managing Director at Piper Jaffray, Inc. from 1992 to 2002, Director-Business Development at Curative Technologies, Inc. from 1992 to 1993, Independent Director at Achieve Life Sciences, Inc. from 2023 to 2026, and Chief Operating Officer at Oracle Partners LP from 2002 to 2007.
Education includes undergraduate studies at Occidental College and an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 0 ( -.--% ) | - $ | 2026-07-30 | |
| 2026-06-09 | 0 ( -.--% ) | - $ | 2026-07-30 | |
EYEPOINT, INC. -.--% | 2026-04-20 | 0 ( -.--% ) | - $ | 2026-07-30 |
| 2026-06-23 | 0 ( -.--% ) | - $ | 2026-07-30 |
Stuart Duty active positions
| Companies | Position | Start |
|---|---|---|
| EYEPOINT, INC. | Director/Board Member | 2023-10-15 |
| MILESTONE PHARMACEUTICALS INC. | Director/Board Member | 2024-07-13 |
| FOGHORN THERAPEUTICS INC. | Director/Board Member | 2025-04-30 |
Former positions of Stuart Duty
| Companies | Position | End |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Director/Board Member | 2026-07-01 |
Guggenheim Partners LLC
 Guggenheim Partners LLC Investment ManagersFinance Provides investment and financial services | Corporate Officer/Principal | 2023-02-28 |
Oracle Partners LP | Chief Operating Officer | 2006-12-31 |
Piper Jaffray, Inc.
 Piper Jaffray, Inc. Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 2001-12-31 |
Montgomery Securities, Inc.
 Montgomery Securities, Inc. Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 1998-12-31 |
Training of Stuart Duty
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
Oracle Partners LP | Finance |
Montgomery Securities, Inc.
Montgomery Securities, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Curative Technologies, Inc.
 Curative Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Biopharmaceutical research | Commercial Services |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Occidental College
 Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guggenheim Partners LLC
Guggenheim Partners LLC Investment ManagersFinance Provides investment and financial services | Finance |
Piper Jaffray, Inc.
Piper Jaffray, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
- Stock Market
- Insiders
- Stuart Duty
